
Lantern Pharma (LTRN) Earnings Dates & Reports
Lantern Pharma (LTRN) Most Recent Earnings
Report DateNov 13, 2025
Period EndingQ3 2025
Est. EPS-$0.46
Actual EPS-$0.39
EarningsBeat
Lantern Pharma (LTRN) Earnings
View the latest Lantern Pharma (LTRN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Lantern Pharma (LTRN)
Order type
Buy in
Order amount
Est. shares
0 shares
Lantern Pharma (LTRN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Lantern Pharma (LTRN) Latest Earnings
The value each LTRN share was expected to gain vs. the value each share gained.
Lantern Pharma (LTRN) reported its most recent earnings on Nov 13, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.39. This exceeded analysts' expectations of -$0.46 by 15.22%, marking a Beat.
For comparison, Lantern Pharma reported EPS of -$0.42 in the same quarter last year.
The company is expected to announce its next earnings report on 03/26/2026, with analysts projecting an EPS of -$0.45.
Lantern Pharma (LTRN) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
|---|---|---|---|---|
Q4 2025Mar 27, 2026 | -$0.45 | Next earnings call Mar. 26, 2026 | ||
Q3 2025Nov 13, 2025 | -$0.46 | -$0.39 | -15.22% | |
Q2 2025Aug 13, 2025 | -$0.50 | -$0.40 | -20.00% | |
Q1 2025May 15, 2025 | -$0.49 | -$0.42 | -14.29% | |
Q4 2024Mar 27, 2025 | -$0.51 | -$0.54 | +5.88% | |
Lantern Pharma (LTRN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Lantern Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Nov 12, 2025 | — | — | — |
| Aug 13, 2025 | — | — | — |
| May 15, 2025 | — | — | — |
| Mar 27, 2025 | — | — | — |
Lantern Pharma (LTRN) Earnings FAQs
Lantern Pharma (LTRN) last reported earnings on Nov 13, 2025 for Q3 2025, posting an EPS of -$0.39, which Beat the estimate of -$0.46 by 15.22%.
For Q3 2025, Lantern Pharma (LTRN) reported an EPS of -$0.39, exceeding analysts' estimate of -$0.46 by 15.22%.
For Q3 2025, Lantern Pharma (LTRN) Beat expectations with an actual EPS of -$0.39 vs. an estimated EPS of -$0.46.
Following the last earnings report on Nov 13, 2025, Lantern Pharma (LTRN)'s stock price moved — from — to —.
The next Lantern Pharma (LTRN) earnings call is scheduled for Mar. 26, 2026, where executives will discuss financial results and outlook.